Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- PMID: 32966561
- DOI: 10.5858/arpa.2020-0310-SA
Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Abstract
Context.—: Covert severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections could be seeding new outbreaks. How to identify asymptomatic SARS-CoV-2 infections early has become a global focus.
Objective.—: To explore the roles of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies detection, nucleic acid tests, and computed tomography (CT) scanning to identify asymptomatic SARS-CoV-2 infection.
Design.—: The clinical data of 389 individuals with close contacts, including in general characteristics, SARS-CoV-2 etiology, serum-specific IgM and IgG antibody detection and CT imaging results, were systematically analyzed.
Results.—: The present study showed that only 89 of 389 individuals with close contacts were positive after the first nucleic acid test, while 300 individuals were still negative after 2 nucleic acid tests. Among the 300 individuals, 75 did not have pneumonia, and the other 225 individuals had pulmonary imaging changes. A total of 143 individuals were eventually diagnosed as having asymptomatic infection through IgM antibody and IgG antibody detection. The sensitivity, specificity, and false-negative rate of IgM and IgG antibody detection were approximately 97.1% (347 of 357), 95.3% (204 of 214), and 4.67% (10 of 214), respectively. It also indicated that during approximately 2 weeks, most individuals were both IgM positive and IgG positive, accounting for 68.57% (72 of 105). During approximately 3 weeks, the proportion of IgM-positive and IgG-positive individuals decreased to 8.57% (9 of 105), and the proportion of IgM-negative and IgG-positive individuals increased to 76.19% (80 of 105).
Conclusions.—: There are highlighted prospects of IgM/IgG antibody detection as a preferred method in identifying the individuals with asymptomatic SARS-CoV-2 infection, especially combined with nucleic acid tests and pulmonary CT scanning.
© 2021 College of American Pathologists.
Similar articles
-
Analysis of Nucleic Acid and Antibody Detection Results for SARS-CoV-2 Infection.Arch Iran Med. 2021 May 1;24(5):427-433. doi: 10.34172/aim.2021.61. Arch Iran Med. 2021. PMID: 34196209
-
Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.Virol Sin. 2020 Dec;35(6):744-751. doi: 10.1007/s12250-020-00268-5. Epub 2020 Jul 27. Virol Sin. 2020. PMID: 32720214 Free PMC article.
-
Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.J Med Virol. 2021 May;93(5):2857-2866. doi: 10.1002/jmv.26741. Epub 2021 Mar 1. J Med Virol. 2021. PMID: 33331654
-
Seroprevalence of Immunoglobulin M and G Antibodies against SARS-CoV-2 Virus: A Systematic Review and Meta-Analysis Study.Iran J Immunol. 2021 Mar;18(1):34-46. doi: 10.22034/iji.2021.87723.1824. Iran J Immunol. 2021. PMID: 33787512
-
Seropositivity rate and diagnostic accuracy of serological tests in 2019-nCoV cases: a pooled analysis of individual studies.Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10208-10218. doi: 10.26355/eurrev_202010_23243. Eur Rev Med Pharmacol Sci. 2020. PMID: 33090430 Review.
Cited by
-
A gold nanoparticles-based lateral flow assay utilizing baculovirus expressed recombinant nucleocapsid and receptor binding domain proteins for serodetection of IgG and IgM against SARS-CoV-2.Biotechnol Lett. 2022 Dec;44(12):1507-1517. doi: 10.1007/s10529-022-03316-0. Epub 2022 Nov 1. Biotechnol Lett. 2022. PMID: 36319880 Free PMC article.
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
-
A loop-mediated isothermal amplification-enabled analytical assay for the detection of SARS-CoV-2: A review.Front Cell Infect Microbiol. 2022 Dec 23;12:1068015. doi: 10.3389/fcimb.2022.1068015. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36619749 Free PMC article. Review.
-
Analysis of macular structure in age-related cataract patients with different antibody levels of severe acute respiratory syndrome coronavirus-2 vaccine.Front Immunol. 2022 Nov 9;13:1024124. doi: 10.3389/fimmu.2022.1024124. eCollection 2022. Front Immunol. 2022. PMID: 36439098 Free PMC article.
-
Silent SARS-CoV-2 Infections, Waning Immunity, Serology Testing, and COVID-19 Vaccination: A Perspective.Front Immunol. 2021 Sep 21;12:730404. doi: 10.3389/fimmu.2021.730404. eCollection 2021. Front Immunol. 2021. PMID: 34621274 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous